These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6538708)

  • 1. Cis-diamminedichloroplatinum activity in bidimensionally measurable metastatic lesions of bladder carcinoma.
    De Lena M; Lorusso V; Iacobellis U; Marzullo F; Maiello E; Cramarossa A
    Tumori; 1984 Feb; 70(1):85-8. PubMed ID: 6538708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin as adjunctive treatment for invasive bladder carcinoma: tolerance and toxicities.
    Einstein AB; Shipley W; Coombs J; Cummings KB; Soloway MS; Hawkins I
    Urology; 1984 Apr; 23(4 Suppl):110-7. PubMed ID: 6538712
    [No Abstract]   [Full Text] [Related]  

  • 3. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
    Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
    Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
    Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of advanced bladder cancer with cis-diamminedichloroplatinum (II NSC 119875): a pilot study.
    Merrin C
    J Urol; 1978 Apr; 119(4):493-5. PubMed ID: 650753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: an effective regimen with low toxicity.
    Lin CC; Hsu CH; Huang CY; Cheng AL; Chen J; Vogelzang NJ; Pu YS
    Cancer; 2006 Mar; 106(6):1269-75. PubMed ID: 16470604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial cisplatin, doxorubicin, and cyclophosphamide (CAP) in the treatment of urothelial transitional cell carcinoma.
    Campbell M; Baker LH; Opipari M; Al-Sarraf M
    Cancer Treat Rep; 1981; 65(9-10):897-9. PubMed ID: 7196800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phase II study on cis-diamminedichloroplatinum (II) by a collaborative study].
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):46-54. PubMed ID: 6892191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin plus oral etoposide in the treatment of patients with advanced small cell lung cancer. Japan Clinical Oncology Group.
    Asamoto H; Kawahara M; Iwami F; Kuba M; Furuse K; Tamura T; Saijo N; Shimoyama M
    Jpn J Clin Oncol; 1998 Dec; 28(12):745-8. PubMed ID: 9879292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and toxicity of two modalities of etoposide infusion in metastatic non-small-cell lung carcinoma.
    Chatelut E; Chevreau C; Blancy E; Lequellec A; Canal P; Roche H; Houin G; Bugat R
    Cancer Chemother Pharmacol; 1990; 26(5):365-8. PubMed ID: 2170043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination therapy with 5-fluorouracil (5-FU), cisplatin (CDDP) and interferon alpha-2B (IFN alpha-2B) for advanced renal cell carcinoma].
    Fujinami K; Ikeda I; Miura T; Kondo I
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1689-91. PubMed ID: 8886046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials of cis-diamminedichloroplatinum (NSC-119875).
    Lippman AJ; Helson C; Helson L; Krakoff IH
    Cancer Chemother Rep; 1973 Apr; 57(2):191-200. PubMed ID: 4126381
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination chemotherapy with cis-diamminedichloroplatinum and vinblastine in advanced non-small cell lung cancer.
    Woodcock TM; Blumenreich MS; Richman SP; Kubota TT; Gentile PS; Allegra JC
    J Clin Oncol; 1983 Apr; 1(4):247-50. PubMed ID: 6686848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of cisplatin in small cell carcinoma of the lung.
    Levenson RM; Ihde DC; Huberman MS; Cohen MH; Bunn PA; Minna JD
    Cancer Treat Rep; 1981; 65(9-10):905-7. PubMed ID: 6268297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
    Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
    Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of cis-diamminedichloroplatinum in patients with non-small cell lung cancer.
    Fujita J; Saijo N; Eguchi K; Shimizu E; Shinkai T; Tominaga K; Sasaki Y; Futami H; Sakurai M; Hoshi A
    Jpn J Cancer Res; 1985 May; 76(5):420-3. PubMed ID: 3924714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative activity and toxicity of cis-diamminedichloroplatinum (DDP) and a combination of doxorubicin, cyclophosphamide, and DDP in disseminated transitional cell carcinomas of the urinary tract.
    Khandekar JD; Elson PJ; DeWys WD; Slayton RE; Harris DT
    J Clin Oncol; 1985 Apr; 3(4):539-45. PubMed ID: 3884746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of dose intensification with cisplatin and carboplatin plus vindesine in patients with inoperable non-small cell lung cancer.
    Nakanishi Y; Takayama K; Kawasaki M; Yatsunami J; Inutsuka S; Wakamatsu K; Tsuruta N; Hara N
    Am J Clin Oncol; 1997 Aug; 20(4):393-7. PubMed ID: 9256897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of toxic effects of cis-diamminedichloroplatinum (NSC-119875)--phase I clinical study.
    Talley RW; O'Bryan RM; Gutterman JU; Brownlee RW; McCredie KB
    Cancer Chemother Rep; 1973; 57(4):465-71. PubMed ID: 4762440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.